Zinc acetate

Zinc acetate (CAS No.: 557-34-6) is a zinc salt widely used as an inorganic small molecule research reagent in immunology, inflammation biology, metal homeostasis, and oncology related discovery workflows, with functional relevance as a bioavailable zinc donor that modulates zinc dependent stress response and immune regulatory processes in experimental systems. Mechanistic evidence indicates that it can enhance HSP 70 mRNA expression, promote metallothionein induction in intestinal cell models, and influence cellular redox and protein quality control networks through zinc sensitive transcriptional regulation, while also restoring splenocyte proliferative capacity and cytokine production and reducing splenocyte apoptosis in endotoxemia associated murine studies, findings consistent with a role in regulation of inflammatory injury and immune dysfunction pathways. In cancer biology settings, zinc acetate has been reported to induce rapid cell death in prostate cancer cell lines in vitro and to suppress growth of prostate cancer xenografts in immunodeficient mouse models, supporting its use as a mechanistic probe for zinc dependent vulnerability and tumor microenvironment response rather than any clinical application. Quantitative potency metrics such as standardized IC50 or EC50 values are not uniformly established across assay formats, and reported activities are generally context dependent and observed across concentration windows that commonly span micromolar to millimolar experimental conditions for ionic zinc salts, with exact concentrations determined by medium composition, exposure duration, and model specific sensitivity. Typical applications include pathway interrogation in LPS responsive immune cell and endotoxemia models, evaluation of metallothionein and heat shock signaling in epithelial systems, and inclusion in phenotypic or mechanism guided screening panels where the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives.